
Alexion data at 2026 AAN Annual Meeting reflects industry-leading portfolio and commitment to enhancing care across rare diseases
<a href="https://news.google.com/rss/articles/CBMikwJBVV95cUxOYUw2RGVQRWJjeTVCTnFuczVWODBEd2otMjV1RDNnd2xnYVRPM1dFb2tBRDJ5eFdqNk96Q0dDV1lSTTEwOWppUWlDTUI2QU4tOFVudDVaTU10NF9tQ3VzRmtUWlpOay1SWVRUc1JwenFaWnZTYzdOVjJ5WkhEbU5aYWR1M25jTUhWcU5halNpYnVSZmd4R0szVm1iQk4wcmlPcHIwaldlbG9HRklIRWlBYjJPSzh3LWFVMkw1RXhfSjZqaUMwT0dIZXdZOG9XZGdydk9xNG04MTZIZkRuSmx2cXZXMFMzd1Vock94c2tlRzM1WFdNSkFKSUpxOEViSFMtX1V6OUhVR01YX3hBX2dXWHljSQ?oc=5" target="_blank">Alexion data at 2026 AAN Annual Meeting reflects industry-leading portfolio and commitment to enhancing care across rare diseases</a>&nbsp;&nbsp;<font color="#6f6f6f">AstraZeneca</font>

